SigSci Awarded Contract to Develop Single-use Synthetic Opioid Detection System
AUSTIN, TEXAS – May 25, 2021 – The U.S. Navy has awarded a one-year, $292,814.70 contract to Signature Science for the development of a self-contained, single-use lateral flow immunoassay (LFA) system for the detection of synthetic opioids, such as fentanyl. First responders currently use procedures to detect synthetic opioids that... MORE